O=[N+]([O-])c1ccc(S[C@H]2[C@H]3C[C@@H](Cl)[C@@H]2c2c(-c4ccccc4)[nH]c(-c4ccccc4)c23)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?